PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 373 of 673

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Concord Biotech: Q1 FY27 Revenue Jumps 26% to ₹257.5 Crore

InvestyWiseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Safety Review 2026 Exposes Why Pills To Lose Weight Rarely Deliver Lasting Results [SAwa8ztf72m]

Diario ASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bharat Biotech MD calls on students to contribute meaningfully to society

The HinduOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A new ADHD drug just got FDA approval. Here's what makes it different.

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dr Reddy’s wins FDA nod for rituximab biosimilar

ET PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Preoperative Dual Immunotherapy Shows Promise in High-Risk Early HER2-Negative Breast Cancer

Bioengineer.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Apnimed Plans IPO to Raise $150 Million for Sleep Apnea Drug

Intellectia AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pfizer’s LITFULO clears two Phase 3 vitiligo trials paving way for global regulatory filings

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk's Phase 3 ZEUS trial misses cardiovascular endpoint for Ziltivekimab

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Should Clinicians Weigh Kidney Cancer Data From ASCO 2026?

CancerNetworkOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

North China Pharmaceutical Company Ltd. Class A Revenue Breakdown – SSE:600812

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Redefining HIV Management: Emerging Antiretroviral Drug Classes and Immunologic Strategies Shaping the Future of HIV Treatment, Prevention

Contagion LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kathua Biotech Park to Drive Innovation & Jobs in J&K, North India

Rediff MoneyWizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Concord Biotech Q1 Results: Net profit rises 31% YoY to ₹57.7 crore

scanx.tradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO Revenue Breakdown – OTC:SKBHF

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Greater Philadelphia – Regional Life Sciences Roundup – July 31, 2026

BioBuzzOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Exposing The Most Dangerous Celebrity Skincare Launches Food (ej86YVXAPF)

MshaleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Third Dimension of Antibody Therapy

BioSpectrum AsiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk's Failed Heart Drug Trial Deepens a Season of Setbacks

ad-hoc-news.deOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Concord Biotech shareholders approve enhanced loan limits at AGM

scanx.tradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bremelanotide Erectile Dysfunction Men Clinical Trial: What The Data Shows For Mens Sexual Health [c4FfBikXfav]

Diario ASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech International Limited Reports Strong FY2025 Performance

indiasnews.netOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Yemeni Honey: From Natural Resource to Promising Pillar for Pharmaceutical Industry

saba.yeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Karnataka to ban junk food around schools

The New Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

North Indias First Industrial Biotech Park At Kathua To Drive J&Ks Biotechnology Revolution: Dr Jitendra

Daily ExcelsiorOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

North India’s First Biotech Park At Kathua, A Hub Of Biotech Driven Entrepreneurship In The Region: Dr. Jitendra

Daily ExcelsiorOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Kolmar BioTech. Inc. – KRX:215380

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sun Pharma shareholders approve all resolutions at 34th AGM

scanx.tradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Scientific advisory board tasked with setting path for fragile skin treatment

epidermolysisbullosanews.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments

Inside Precision MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Drug Safety Has Become India's Next Pharmaceutical Imperative

BioSpectrum IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Janus Henderson Group PLC Has $145.08 Million Position in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RTW Biotech Opportunities Ltd USD Revenue Breakdown – FWB:0BM

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Over 1,500 experts attended the Hanoi Hospital Pharmaceutical Science Conference (expanded) in Nghe An.

Vietnam.vnOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fluctuations in entrance exam scores for medical and pharmaceutical schools in the North over the past 3 years, with "hot" majors exceeding 27 points.

Vietnam.vnOriginal source
🌍Regulatorywho.intTier 1 · Regulatory source

Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo

WHO Disease Outbreak NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech Inc (KRYS) Valuation: PE, PB & Fair Value Analysis

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Axiom Investment Management LLC Takes $965,000 Position in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VYLOY (zolbetuximab) in combination with chemotherapy is NOW AVAILABLE and approved for first-line treatment of eligible* adult patients with gastric or gastroesophageal junction adenocarcinoma in India

The Eastern HeraldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech (MBRX US): Synthetic Expert Call Transcript (01 Aug 2026)

SmartkarmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sichuan Kelun Biotech (SEHK:6990) Wins Priority Review For Sixth Sac TMT Indication

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd. $TEVA Stake Boosted by Avidity Partners Management LP

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical (COLL.US) will release its earnings report before the market opens on August 6.

google_newsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Lushang Freda Pharmaceutical Co., Ltd. Class A – SSE:600223

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VKTX Launches $500M Shelf After Full Enrollment Of Phase 3 Obesity Drug Study – Retail Bets On ‘Exceptionally Great Data’

StocktwitsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Routine Health Data Is Outperforming Trial Data for AI Training. The FDA Hasn’t Caught Up.

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is Reta Safe?

Yahoo CreatorsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vidipha Central Pharmaceutical JSC Revenue Breakdown – HOSE:VDP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Keros Receives $20M Milestone as Elritercept Phase 3 Trial Enrolls First Patient

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech updates Annamycin data, prices stock offering at $0.75

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Latest Glp 1 Weight Loss Drug News Today: Breakthroughs And Updates [B80XXaMIG4d]

Diario ASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Radiopharm reports positive phase 2b results for RAD 101 imaging agent

Investing.com UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China recruits 105 top US scientists as biotech race intensifies

e.vnexpress.netOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Drug Safety Has Become India's Next Pharmaceutical Imperative

BioSpectrum IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Crackdown: Hotel Associations Urge Due Process, Oppose Public Naming Before Legal Proceedings End

PUNE PULSEOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA crackdown: Why hotel bodies want Modi, Fadnavis to step in

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Investors Are Reacting To Disc Medicine (IRON) Balancing Larger Losses With APOLLO Phase 3 FDA Alignment

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Veraxa Biotech AG – NASDAQ:VRXA

TradingViewOriginal source